BlankBio
Predict disease progression and identify patients most likely to respond to therapy using RNA foundation models.
An AI platform that applies foundation models to bulk RNA-seq data, solving the problem of expensive clinical trial failures caused by limited insight into patient biology. It sells to pharma teams and clinical development leaders at pharmaceutical companies. The platform is delivered as a cloud-based SaaS, distinguishing itself by leveraging RNA intelligence to predict disease progression and optimize patient selection for trials.
Key features
- Predict disease progression from RNA data
- Design smaller trials with prognostic scores
- Identify patient responders for therapies
- Detect emerging resistance mechanisms
- Identify combination therapy strategies
- No social media activity within the last 30 days
GTM channels
- No GTM activity detected
ICP
- Healthcare providers
- Data analytics teams
- Enterprises